Race Oncology Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.166x

Race Oncology Ltd cash flow conversion efficiency. Based on the latest financial reports, Race Oncology Ltd (RAC) has a cash flow conversion efficiency ratio of -0.166x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.06 Million ≈ $-4.29 Million USD) by net assets (AU$36.45 Million ≈ $25.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Race Oncology Ltd (2011–2026)

Cash flow conversion efficiency of Race Oncology Ltd from 2011 to 2026. This chart illustrates how Race Oncology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RAC share price today for real-time trading data and today's change.

Race Oncology Ltd Cash Flow Conversion Ratio Explained

Race Oncology Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Race Oncology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Race Oncology Ltd ranked by their cash flow conversion efficiency. Also see RAC stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Vizsla Royalties Corp. V:VROY	-0.007x
Henan BCCY Environmental Energy Co. Ltd SHE:300614	N/A
Condor Energies Inc. TO:CDR	0.082x
Ace Pillar Co Ltd TW:8374	0.032x
BAJEL PROJECTS LTD NSE:BAJEL	0.009x
P.C.B Tec TA:PCBT	0.056x
Blue Bird Tbk PT JK:BIRD	0.040x
Omaxe Limited NSE:OMAXE	0.064x

Annual Cash Flow Conversion Efficiency for Race Oncology Ltd (2011–2026)

The table below shows the annual cash flow conversion efficiency of Race Oncology Ltd from 2011 to 2026. Review how much free cash does Race Oncology Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$36.45 Million ≈ $25.79 Million	AU$-8.25 Million ≈ $-5.83 Million	-0.226x	+20.80%
2025-06-30	AU$16.01 Million ≈ $11.33 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.286x	+45.19%
2024-06-30	AU$18.31 Million ≈ $12.96 Million	AU$-9.55 Million ≈ $-6.75 Million	-0.521x	-24.73%
2023-06-30	AU$25.49 Million ≈ $18.03 Million	AU$-10.65 Million ≈ $-7.54 Million	-0.418x	-141.15%
2022-06-30	AU$36.11 Million ≈ $25.55 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.173x	+49.37%
2021-06-30	AU$13.72 Million ≈ $9.71 Million	AU$-4.70 Million ≈ $-3.32 Million	-0.342x	+20.92%
2020-06-30	AU$5.69 Million ≈ $4.03 Million	AU$-2.46 Million ≈ $-1.74 Million	-0.433x	+18.25%
2019-06-30	AU$5.05 Million ≈ $3.57 Million	AU$-2.67 Million ≈ $-1.89 Million	-0.530x	-8.53%
2018-06-30	AU$7.93 Million ≈ $5.61 Million	AU$-3.87 Million ≈ $-2.74 Million	-0.488x	-11.53%
2017-06-30	AU$5.64 Million ≈ $3.99 Million	AU$-2.47 Million ≈ $-1.74 Million	-0.437x	-482.87%
2016-06-30	AU$4.08 Million ≈ $2.89 Million	AU$-306.06K ≈ $-216.56K	-0.075x	+99.59%
2015-06-30	AU$5.69K ≈ $4.02K	AU$-103.69K ≈ $-73.37K	-18.233x	-3337.39%
2014-06-30	AU$-70.24K ≈ $-49.70K	AU$-39.56K ≈ $-27.99K	0.563x	+1402.35%
2013-12-31	AU$98.97 Million ≈ $70.02 Million	AU$3.71 Million ≈ $2.63 Million	0.037x	+284.33%
2013-06-30	AU$93.38K ≈ $66.07K	AU$-1.90K ≈ $-1.34K	-0.020x	-128.73%
2012-06-30	AU$94.45 Million ≈ $66.83 Million	AU$6.68 Million ≈ $4.73 Million	0.071x	-36.42%
2011-06-30	AU$107.05 Million ≈ $75.74 Million	AU$11.92 Million ≈ $8.43 Million	0.111x	--

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$204.63 Million

AU$289.20 Million AUD

Market Cap Rank

#16218 Global

#445 in Australia

Share Price

AU$1.48

Change (1 day)

-0.34%

52-Week Range

AU$1.40 - AU$3.46

All Time High

AU$4.70